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Effects of PS1 Deficiency on Membrane
Protein Trafficking in Neurons
Early-onset familial forms of AD are caused by autoso-
mal dominant inheritance of mutations in genes encod-
ing APP (reviewed in Selkoe, 1997), presenilin 1 (PS1),
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and presenilin 2 (PS2) (reviewed in Hardy, 1997). PS1,Xiaozhong Qian,2 David D. Ginty,2 Donald L. Price,1,2,3,4
a polytopic membrane protein (Doan et al., 1996; Li andDavid R. Borchelt,1,4 Philip C. Wong,1,4
Greenwald, 1998), is structurally and functionally homol-and Sangram S. Sisodia7,8
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segmentation and loss of segment polarity that lead toThe Johns Hopkins University School of Medicine
patterning defects in axial skeleton and spinal ganglia,Baltimore, Maryland 21205
and hemorrhages in the CNS (Shen et al., 1997; Wong5 National Institute of Aging
et al., 1997). Very recently, De Strooper and colleaguesBaltimore, Maryland 21224
(1998) documented that primary neuronal cultures gen-6 Department of Neuropathology and Neuroscience
erated from PS12/2 mouse embryos fail to secrete AbFaculty of Pharmaceutical Sciences
peptides, coincident with intracellular accumulations ofUniversity of Tokyo
APP C-terminal fragments (CTFs) containing varyingTokyo 113
segments of the Ab sequence. These observations wereJapan
interpreted to suggest that PS1 influences intramembra-7 Department of Pharmacological
nous g-secretase processing of APP. Despite the nov-
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elty of these latter conclusions, little information was
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In the present manuscript, we examine the metabo-
lism and trafficking of a variety of membrane and secre-
tory proteins in primary neurons lacking PS1. ConfirmingSummary
the studies by De Strooper and coworkers (1998), we
demonstrate that PS1-deficient neurons fail to secreteWe have examined the trafficking and metabolism of
Ab. In contrast to the studies by De Strooper and col-the b-amyloid precursor protein (APP), an APP homo-
leagues, however, we document that the rate of appear-log (APLP1), and TrkB in neurons that lack PS1. We
ance of soluble APP (APPsa) derivatives in medium ofreport that PS1-deficient neurons fail to secrete Ab,
PS1-deficient neurons is quantitatively increased. Re-and that the rate of appearance of soluble APP deriva-
markably, a CTF derived from amyloid precursor-liketives in the conditioned medium is increased. Remark-
protein 1 (APLP1), also accumulates in PS1-deficientably, carboxyl-terminal fragments (CTFs) derived from
neurons; in view of the limited homology between theAPP and APLP1 accumulate in PS1-deficient neurons.
APP and APLP1 transmembrane domains, we concludeHence, PS1 plays a role in promoting intramembrane
that PS1 has a much broader role in promoting intra-cleavage and/or degradation of membrane-bound
membrane cleavage and/or degradation of CTFs de-CTFs. Moreover, the maturation of TrkB and BDNF-
rived from APP, its homologs, and perhaps other trans-
inducible TrkB autophosphorylation is severely com-
membrane polypeptides. Moreover, we now document
promised in neurons lacking PS1. We conclude that that the rate of acquisition and steady-state levels of
PS1 plays an essential role in modulating trafficking complex oligosaccharide modifications of TrkB, a ty-
and metabolism of a selected set of membrane and rosine kinase receptor for brain-derived neurotrophic
secretory proteins in neurons. factor (BDNF), is diminished in PS1-deficient neurons.
Consistent with these observations, BDNF-mediated
Introduction TrkB autophosphorylation is severely compromised in
PS1-deficient neurons. Interestingly, and with very few
exceptions, the rate and pattern of newly synthesizedAlzheimer's disease (AD), a progressive neurodegenera-
proteins that appear on the plasma membrane and con-tive disorder of late life, is characterized by the deposi-
ditioned medium of wt and PS1-deficient neurons aretion of 42±43 amino acid Ab peptides and neurofibrillary
remarkably similar. These results support the view thattangles in the hippocampus and cerebral cortex of af-
loss of PS1 activity has a highly selective role in thefected individuals. The N and C termini of Ab peptides
trafficking and turnover of selected membrane proteinsare generated following endoproteolytic cleavage of
in neurons.larger type 1 integral membrane b-amyloid precursor
proteins (APP) by ªb-º and ªg-secretaseº activities, re-
Resultsspectively (reviewed in Selkoe, 1997).
Elimination of PS1 Abrogates Ab Secretion
Recent studies by De Strooper and colleagues provided8 To whom correspondence should be addressed (e-mail: ssisodia@
drugs.bsd.uchicago.edu). compelling evidence that primary neurons from PS12/2
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mouse embryos exhibit marked reductions in secretion
of Ab peptides, coincident with the intracellular accumu-
lation of a complex set of APP C-terminal fragments
(CTFs) containing Ab peptide±related sequences (1998).
We prepared cortical neuronal cultures from day 15.5
p.c. PS12/2, PS11/1, or PS11/2 embryos and assayed
steady-state levels of APP metabolites after 5 days. At
this point, surviving neurons appeared morphologically
differentiated, and nonneuronal cells represented ,5%
of all cells in the culture (data not shown). Western blot
analysis of detergent lysates prepared from neuronal
cultures using CT15, an antibody specific for the car-
boxyl-terminal 15 amino acids of APP (Sisodia et al.,
1993; Zheng et al., 1995), revealed that APP CTFs were
markedly elevated in PS12/2 cultures (Figure 1A, lanes
3 and 4), compared to sister cultures prepared from
littermates with PS11/1 or PS11/2 genotypes (Figure 1A,
lanes 1 and 2, respectively), despite equivalent steady-
state levels of z100±120 kDa, full-length APP-695
between samples. In addition, quantitative sandwich
ELISA analyses revealed that in conditioned medium
of PS12/2 neurons, Ab-related peptides terminating at
residue 40 or 42 (x-40 or x-42, respectively) were virtually
eliminated (Figure 1B). Metabolic labeling of neuronal
cultures with 35S-methionine for 5 hr and immunoprecipi-
tation analysis of detergent lysates with CT15 antibody
confirmed the Western blot analyses; while levels of full-
length radiolabeled APP in PS11/2 and PS12/2 cultures
were comparable (Figure 1C, lanes 1 and 2, respec-
tively), radiolabeled APP CTFs accumulated in PS12/2
cells (Figure 1C, lane 2). Moreover, immunoprecipitation
analysis using Mab4G8 (Kim et al., 1990), specific for
epitopes between residues 17±28 of Ab, revealed that
radiolabeled z4 kDa Ab and z3±3.5 kDa Ab-related
peptides, normally secreted into medium of PS11/2 cells,
failed to accumulate in the conditioned medium of
PS12/2 cells (Figure 1C, compare lanes 3 and 4, respec-
tively).
To demonstrate that the accumulation of APP CTFs
in PS12/2 cells is solely a consequence of the loss of
PS1, we examined the steady-state levels of APP metab-
olites in detergent extracts prepared from brains of day
15.5 p.c. PS11/1, PS12/2, and PS12/2 mice rescued by Figure 1. Accumulation of APP C-Terminal Fragments and Reduced
human PS1 transgenes; we (Davis et al., 1998) and oth- Secretion of Ab Peptides from PS12/2 Neurons
ers (Qian et al., 1998) previously documented that the (A) Detergent lysates of PS11/1 (lane 1), PS11/2 (lane 2), and PS12/2
developmental deficits in PS12/2 mice are efficiently res- (lanes 3 and 4) neuronal cell cultures were immunoblotted using
CT15, an antisera recognizing the C terminus of APP. The positionscued by expression of transgenes encoding either hu-
of the full-length APP and the C-terminal fragments (APP CTF) areman PS1 or the FAD-linked, A246E human PS1 variant.
marked by brackets.Similar to the results obtained by analysis of primary
(B) Determination of Abx-40 and Abx-42 levels from conditioned
neuronal cultures, we observed a significant elevation medium of PS11/2 and PS12/2 neuronal cultures. The concentrations
in levels of z8.5±12 kDa CTFs in lysates of PS12/2 brain of Ab peptides for each genotype are plotted (in pM) as mean 6
(Figure 2A, lane 4; compare to levels in PS11/1, lane standard deviation (n 5 7).
(C) Detergent lysates or conditioned media from PS11/2 (lanes 13). Importantly, the APP CTFs exhibit electrophoretic
and 3) and PS12/2 (lanes 2 and 4) neuronal cell cultures radiolabeledmigration similar, if not identical, to CTFs that accumu-
with 35S-methionine were immunoprecipitated with CT15 (lanes 1late in mouse brain (Figure 2A, lane 1) or in the brain of
and 2) or with 4G8, an antisera specific for Ab peptides (lanes 3 andmice that overexpresses a mouse APP-695 transgene
4), respectively. Full-length APP and APP CTF are indicated by
(D. R. B., unpublished data ) (Figure 2A, lane 2). Hence, brackets, and Ab and p3 peptides are marked by arrowheads.
it is highly likely that the mouse APP CTFs which accu-
mulate in PS12/2 brain are generated by constitutive
compare lane 3 to lanes 5 and 6, respectively). Westernactivities rather than alternative or aberrant proteolytic
blot analysis of the brains of rescued PS12/2 mice usingevents. Moreover, the APP CTFs in brains of PS12/2
aPS1loop, an antibody specific for PS1 epitopes be-mice are almost completely restored to wild-type levels
tween amino acids 300±360 (Thinakaran et al., 1996),upon expression of human transgenes encoding either
human PS1 or the A246E human PS1 variant (Figure 2A, revealed the presence of a C-terminal PS1 fragment,
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Figure 2. APP CTF Are Restored to Normal Levels in PS12/2 Res-
cued Embryos
(A) Total proteins (30 mg) extracted from brains of 2-month-old con-
trol (lane 1) and transgenic mouse expressing APP transgene (lane
2) or E15.5 control (lane 3), PS12/2 (lane 4), PS12/2;huPS1wt (lane
5), and PS12/2;A246E (lane 6) embryos were analyzed by immu-
noblotting using APP-specific antibody CT15. Full-length APP and
APP CTF are indicated.
(B) Protein extracts from E15.5 control (lane 3), PS12/2 (lane 4),
PS12/2;huPS1wt (lane 5), and PS1-/-;A246E (lane 6) brain were sub-
jected to immunoblotting with a PS1-specific antibody, aPS1Loop,
specific for epitopes in the ªloopº domain of mouse and human
PS1.
(C) The blot in (B) was stripped, then reprobed with a b-tubulin-
specific monoclonal antibody.
generated by endoproteolytic cleavage of transgene-
encoded human PS1 (Figure 2B, lanes 3 and 4, respec-
tively).
Figure 3. Altered APP Metabolism in PS12/2 Neurons
(A) Following 3 days of infection with adenovirus expressing humanPS1 Exerts Multiple Effects on APP Metabolism
APP, PS11/2 (lanes 1, 3, and 5) and PS12/2 (lanes 2, 4, and 6)
The highly reproducible observation that PS1-deficient neuronal cultures were pulse-labeled for 1 hr (lanes 1 and 2) with
neurons fail to secrete Ab peptides and accumulate APP 35S-methionine, then chased in the presence of L-methionine for 2
hr (lanes 3 and 4) and 4 hr (lanes 5 and 6). Full-length APP and CTFCTFs (De Strooper et al., 1998; Figure 1, above) left open
of APP were immunoprecipitated with CT15. Arrow indicates anthe possibility that loss of PS1 activity might have more
z8.5 kDa CTF.widespread influences on APP metabolism. In this re-
(B) Ab and p3 peptides; (C) soluble APP derivatives (APPs) or (D)
gard, De Strooper and colleagues reported that neuronal
a-secretase-generated APPs (APPsa) were immunoprecipitated with
secretion of C-terminally truncated APP derivatives, 4G8, P2-1, or 6E10 antisera, respectively, from conditioned media
termed APPsa and APPsb, generated by endoproteolytic of the corresponding neuronal cultures as shown in (A). Lanes 1
and 2 of (C) were from conditioned media of wt neuronal culturescleavage by a- or b-secretase(s), respectively, are not
labeled for 5 hr with 35S-methionine.influenced by the loss of PS1. To corroborate these
(E) Quantitative analysis of APPsa release. Experiments were per-findings, we examined the maturation and processing
formed in triplicate on different days. The APPsa signals at each
of APP in PS11/2 and PS12/2 primary neurons following point of the pulse-chase experiments were quantified by phospho-
infection with a recombinant adenovirus harboring cDNA imaging. Error bar is SEM.
encoding wild-type human APP695. Cells were infected
for 3 days, pulse-labeled in medium containing 35S- the 1 hr labeling period (Figure 3A, lanes 1 and 2, respec-
methionine for 1 hr, then chased for either 2 or 4 hr tively), the level of an z8.5 kDa polypeptide was clearly
in medium containing unlabeled L-methionine. APP- elevated in PS12/2 cells (Figure 3A, lane 2). While the
related polypeptides were immunoprecipitated from de- identity of this fragment has not been established, it
tergent lysates using CT-15 antibody. While full-length likely represents the membrane-retained APP CTF gen-
z100±125 kDa APP and z9±12 kDa APP CTFs accumu- erated by a-secretase cleavage of APP (see below, Fig-
ure 3D). After 2 hr of chase, the z8.5 kDa and z9±10lated to similar levels in PS11/2 and PS12/2 cells after
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kDa APP CTFs, presumably generated after cleavage transit the secretory apparatus and encounter a-secre-
at or near Ab 111 (De Strooper et al., 1995; Simons et al., tase at or near the plasma membrane.
1996), accumulate to markedly higher levels in PS12/2
cultures compared to CTFs in PS11/2 cultures (Figure PS1 Influences Metabolism of APLP1
3A, compare lane 4 with lane 3). After 4 hr of chase, One interpretation of the observation that loss of PS1
APP CTFs in PS11/2 cultures were nearly eliminated,
leads to accumulation of APP C-terminal fragments and
while in PS12/2 cultures, these fragments were stabilized
inhibition of Ab production (De Strooper et al., 1998;
(Figure 3A, lanes 5 and 6, respectively). Finally, and
Figures 2 and 3, above) is that PS1 selectively facilitates
supporting earlier steady-state experiments (Figure 1B,
APP transmembrane domain cleavage by g-secretase.1C), Ab-related peptides fail to be secreted by PS12/2
To test whether endoproteolysis of additional mem-cultures (Figure 3B, lanes 4 and 6; compare to Ab pep-
brane proteins might be compromised by the loss oftides secreted by PS11/2 cultures, lanes 3 and 5).
PS1, we analyzed the metabolism of APLP1. APLP1,Our observation that the levels of an APP C-terminal
an APP homolog, is uniquely expressed in the nervousfragment of z8.5 kDa are increased in lysates prepared
system (Wasco et al., 1992; von Koch et al., 1998). Al-from PS12/2 cultures immediately after pulse labeling
though APP and APLP1 share significant regions of ho-(Figure 3A, lane 2) suggested that the rate of a-secretase
mology in the ectodomain and cytosolic domains, theprocessing of APP might be influenced by the loss of
homology between the APP and APLP1 transmembranePS1. To clarify this issue, we first immunoprecipitated
domains is limited, particularly at the APP ªg-secretaseºradiolabeled soluble APP derivatives (APPs) with MabP2-1,
sites (arrows) (Figure 4A). We stripped, then reprobeda monoclonal antibody specific for an epitope in the
the Western blot of embryonic brain extracts shown inhuman APP ectodomain (Van Nostrand et al., 1989).
Figure 2A with CT11, a polyclonal antisera specific forAs expected, P2-1 failed to detect mouse APPs in the
epitopes in the C terminus of APLP1 (von Koch et al.,conditioned medium of uninfected PS11/2 or PS12/2 cul-
1998). While the steady-state levels of full-length z90±tures (Figure 3C, lanes 1 and 2, respectively). However,
120 kDa APLP1 were identical between samples, anand most surprisingly, an z110 kDa human APPs was
z7.5 kDa APLP1 C-terminal fragment was elevated inelevated in the conditioned medium of PS12/2 cultures
the PS12/2 brain extract (Figure 4B, lane 2). Moreover,immediately after the pulse-labeling period (Figure 3C,
and highly reminiscent of the results shown in Figure 2A,compare lane 4 to PS11/2 medium in lane 3), and this
expression of transgene-encoded wild-type or A246Edifference is still apparent after 2 hr in chase medium
human PS1 variants in a PS12/2 background restored(Figure 3C, compare lane 6 to PS11/2 medium in lane
the APLP1 C-terminal fragment to levels normally ob-5). After 4 hr, the levels of APPs in the medium of PS11/2
served in PS11/1 animals (Figure 4B, compare lanes 3and PS12/2 cultures appear similar (Figure 3C, compare
and 4 with lane 1). Similarly, immunoprecipitation analy-lanes 7 and 8, respectively). To quantitatively assess
the levels of a-secretase (APPsa)-generated soluble de- sis confirmed that an 35S-methionine-labeled APLP1
rivatives, we subjected the conditioned medium of C-terminal fragment accumulated to significant levels
PS11/2 or PS12/2 cultures to immunoprecipitation with in PS12/2 primary neuronal cultures (Figure 4C, lane 2).
Mab6E10, a monoclonal antibody that selectively binds To examine the biosynthesis and turnover of APLP1
a sequence in the human Ab peptide domain (Kim et C-terminal fragments, we immunoprecipitated APLP1-
al., 1990; Thinakaran et al., 1996). Phosphorimaging related polypeptides from the same detergent extracts
analysis (Figure 3E) revealed that at the end of the 1 of metabolically labeled cultures used in Figure 3A.
hr pulse-labeling period, APPsa in medium of PS12/2 While the levels of z7.5 kDa APLP1 C-terminal frag-
cultures are twice the levels as that observed in medium ments are comparable between PS11/2 and PS12/2 cul-
of PS11/2 cultures (Figure 3D, compare lanes 1 and 2, tures at the end of the 1 hr labeling period (Figure 4C,
respectively; Figure 3E). Thus, the elevated levels of compare lanes 3 and 4, respectively), it is readily appar-
APPsa in medium, coincident with increase in levels of ent that relative to PS11/2 cultures, the APLP1 CTF in
an intracellular APP C-terminal fragment of z8.5 kDa PS12/2 cultures is stabilized over the chase period (Fig-
(Figure 3A, lane 2) in PS12/2 cultures immediately after ure 4C, compare lanes 6 and 8 to 5 and 7). These obser-
pulse labeling, lead us to suggest that loss of PS1 ex- vations, taken together with the earlier demonstration
pression enhances the rate of APP trafficking to the that APP CTFs accumulate in PS1-deficient cells, argue
plasma membrane, the preponderant site for a-secre- in support of the view that loss of PS1 has a more general
tase cleavage of APP (reviewed in Selkoe, 1997). The effect on the turnover of membrane-bound ªstubsº de-
2-fold difference in accumulated APPsa in medium be- rived from transmembrane proteins.
tween PS1-deficient and PS11/2 neurons persists over
the initial 2 hr chase period (Figure 3D, compare lanes
Diminished Functional TrkB Receptors3 and 4, quantified in Figure 3E). After 4 hr of chase,
in PS1-Deficient NeuronsAPPsa in medium of PS12/2 cultures appears to plateau,
Convinced that loss of PS1 activity had multiple effectswhile the levels of APPsa in medium of PS11/2 cultures
on the metabolism of APP and APLP1 and their deriva-now appear comparable to that in medium of PS1-defi-
tives, we asked whether the metabolism of other mem-cient cultures (Figure 3D, compare lanes 5 and 6; quanti-
brane glycoproteins might also be altered in PS1-defi-fied in Figure 3E). Our interpretation of these findings is
cient neurons. For these studies, we chose to examinethat the total pool size of a-secretase substrates in
the maturation of TrkB, a tyrosine kinase receptor spe-PS11/2 or PS12/2 cells is not substantially different.
cific for brain-derived neurotrophic factor (BDNF) (Chao,Rather, in PS12/2 cells, the burst of APPs release corre-
sponds to a pool of newly synthesized APPs that rapidly 1992). PS11/2 and PS12/2 cultures were pulse-labeled
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species of z140±150 kDa within the 2 hr chase period
(Figure 5A, lane 4). On the other hand, in PS12/2 cells,
immature TrkB polypeptides persisted throughout the
chase period and the levels of highly glycosylated spe-
cies were significantly diminished (Figure 5A, lanes 5±8).
It is not presently clear whether reduced TrkB glycosyla-
tion in PS12/2 cells is a reflection of diminished rates of
acquisition of mixed oligosaccharide modifications or
slower transit of TrkB polypeptides through the secre-
tory pathway. In any event, these studies convincingly
demonstrate that in primary cortical neurons, maturation
of TrkB receptors is fundamentally altered by the loss
of PS1.
Despite the striking reduction in levels of fully glycosy-
lated TrkB in PS1-deficient neurons, it was not incon-
ceivable that underglycosylated TrkB polypeptides might
arrive at the surface and still be functional. To test this
hypothesis, we examined the autophosphorylation of
TrkB receptors after treatment of live PS11/1 and PS12/2
primary neurons with BDNF. Cells were incubated for
10 min with 100 ng/ml BDNF, and total cellular TrkB
was immunoprecipitated from detergent lysates using
antibody C14, specific for the C-terminal 14 residues of
Trk receptors; resulting immunocomplexes were sub-
jected to Western blot analysis with phosphotyrosine-
specific antibodies 4G10 and PY99. In contrast to PS11/1
neurons, wherein TrkB receptors undergo robust auto-
phosphorylation after BDNF binding (Figure 5B, lane
2), the levels of autophosphorylated TrkB receptors in
PS12/2 neurons are diminished by z90% (Figure 5B,
lane 4; quantified in Figure 5E). The specificity of BDNF-
induced tyrosine autophosphorylation of TrkB is shown
in Figure 5C; while the general pattern of polypeptides
detected with phosphotyrosine antibodies is identical
between PS11/1 and PS12/2 neurons, the levels of an
z140 kDa polypeptide, corresponding to tyrosine phos-
phorylated TrkB, are specifically induced by BDNF treat-
ment (Figure 5C, arrow).
Having demonstrated that PS1 deficiency alters the
metabolism of APP, APLP1, and TrkB, we assessed the
general effects of loss of PS1 activity on the metabolism
of the neuronal secretory apparatus. First, we examinedFigure 4. Accumulation of APLP1 CTF in PS12/2 Brain and Neuronal
the rate and patterns of appearance of newly synthe-Cultures
sized polypeptides on the plasma membrane. Parallel(A) Comparison of the amino acid sequences of the transmembrane
cultures of PS11/2 and PS12/2 neurons were pulse-domains of APP and APLP1. Arrows denote g-secretase cleavage
labeled with 35S-methionine for 15 min, then chased insites of APP.
(B) Total protein extracts (30 mg) from E15.5 brains of PS11/1 (lane complete medium for 1 hr. Cell surface polypeptides
1), PS12/2 (lane 2), PS12/2;huPS1wt (lane 3), and PS12/2;A246E (lane were modified with biotin and captured with streptavi-
4) mice were analyzed by immunoblotting with an APLP1 specific din. Fractionation of resulting complexes failed to reveal
antibody, CT11. Arrow indicates a C-terminal fragment of APLP1. any differences in the patterns of cell-surface molecules
(C) PS11/2 (lanes 1, 3, 5, and 7) and PS12/2 (lanes 2, 4, 6, and 8)
between PS11/2 and PS12/2 neurons (data not shown).neuronal cultures were pulse-labeled with 35S-methionine for 5 hr
Our second approach was to pulse-label cells, then(lanes 1 and 2) or for 1 hr and chased with L-methionine for 2 or 4 hr
chase in complete medium for varying periods of time.(lanes 3±8). Full-length and CTF of APLP1 were immunoprecipitated
from cell lysates using CT11. Arrow points to the CTF of APLP1. The conditioned medium at each time point was frac-
tionated by SDS-PAGE; again, and with very few excep-
tions, the rates of secretion and accumulation of the
for 15 min in medium containing 35S-methionine and vast majority of polypeptides in medium of PS11/2 and
chased in complete medium for up to 2 hr; TrkB-related PS12/2 cultures were very similar (data not shown).
polypeptides were immunoprecipiated from detergent
lysates using antibody 203 (Ehlers et al., 1995), raised Discussion
against a conserved peptide domain in the C terminus
of all Trk receptors. We document that in PS11/2 cells, A series of preceding efforts have offered compelling
the vast majority of immature z110 kDa TrkB polypep- support for the view that FAD-linked mutant PS1 influ-
ence APP processing in a manner that leads to increasedtides (Figure 5A, lane 1) matured to highly glycosylated
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production of highly amyloidogenic Ab 1-42/43 peptides
(Borchelt et al., 1996; Duff et al., 1996; Scheuner et al.,
1996; Citron et al., 1997). More provocative was the
discovery that primary neuronal cultures from PS1-defi-
cient mouse embryos fail to secrete Ab peptides, coinci-
dent with intracellular accumulation of APP carboxyl-
terminal fragments (CTFs) (De Strooper et al., 1998).
These studies were interpreted as proof that PS1 regu-
lates intramembranous g-secretase processing of APP
(Haass and Selkoe, 1998). Despite the novelty of these
studies, the specificity of PS1 deficiency was not ad-
dressed, a notable omission in view of the paucity of
PS1 expression in mammalian cells (Lee et al., 1996;
Thinakaran et al., 1996) and the striking developmental
deficits in mice lacking PS1 (Shen et al., 1997; Wong et
al., 1997).
In the present report, we offer several insights into
the role of PS1 on the metabolism and trafficking of a
variety of membrane and secretory proteins in primary
neurons. Confirming the studies by De Strooper and
coworkers, we report that PS1-deficient neurons fail to
secrete Ab. However, and in contrast to the earlier
conclusion that accumulated levels of soluble APP de-
rivatives, termed APPsa and APPsb, in the conditioned
medium of primary neurons overexpressing human APP
encoded by recombinant Semliki Forest virus (SFV) vec-
tors are not influenced by the loss of PS1 (De Strooper
et al., 1998), we document that the rate of appearance
of soluble APP (APPsa) derivatives in medium of PS1-
deficient neurons is markedly increased. In view of
abundant evidence that trafficking of overexpressed
membrane proteins rarely mimics that of endogenous
counterparts, we suggest that any differences in APP
trafficking between wt and PS1-deficient neurons would
be masked by SFV-driven overexpression.
One of the central questions in the field pertains to
the mechanism by which PS1 facilitates ªg-secretaseº
cleavage of APP. One model, founded on reports that
APP and presenilins interact (Weidemann et al., 1997;
Xia et al., 1997), proposes that PS1 might serve as an
APP ªchaperoneº to facilitate ªg-secretaseº cleavage
(De Strooper et al., 1998; Haass and Selkoe, 1998). How-
ever, recent studies have failed to confirm the interaction
of APP and presenilin either in cultured cells or brain
(Thinakaran et al., 1998; P. St. George-Hyslop, personal
communication), leading to the alternative proposal that
PS1 has a general affect on the turnover of membrane-
bound metabolites derived from precursor proteins sim-
ply by altering trafficking of these molecules to com-
partments wherein the elusive ªg-secretasesº or other
Figure 5. Reduced Levels of Functional TrkB Receptors in PS12/2 degradative activities are resident. In support of this
Neurons
hypothesis, we report that a CTF derived from an APP
(A) PS11/2 (lanes 1±4) and PS12/2 (lanes 5±8) neuronal cultures were
homolog, APLP1, also accumulates in PS1-deficientpulse-labeled with 35S-methionine for 15 min, then chased for 20,
45, and 120 min. Trk polypeptides were immunoprecipitated from
detergent lysates using Pantrk203, an antisera that recognizes all
Trk receptors. Mature and immature Trk proteins are marked by
brackets. the supernatant fraction from the C14 immunoprecipitation were
(B and C) PS11/1 (lanes 1 and 2) and PS12/2 (lanes 3 and 4) neuronal immunoblotted with 4G10 and PY99. Arrow points to specific BDNF-
cultures were stimulated for 10 min with 100 ng/ml BDNF (lanes 2 induced tyrosine phosphorylated polypeptides.
and 4) or left unstimulated (lanes 1 and 3). In (B), TrkB polypeptides (D) The blot in (C) was stripped and reprobed using a mouse
were immunoprecipitated from detergent lysates with C14, an anti- b-tubulin monoclonal antibody.
sera specific for the C-terminal 14 residues of Trk receptors, and (E) Quantitative analysis of BDNF-mediated TrkB autophosphoryla-
the resultant immunecomplexes were analyzed by immunoblotting tion in wt and PS1-deficient neurons. The bar graph depicts the
with a-phosphotyrosine-specific antibodies 4G10 and PY99. In (C), results of three independent experiments. Error bar is SEM.
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Experimental Proceduresneurons. Considering the extremely limited homology
between the transmembrane domains of APP and APLP1,
Primary Cortical Culturesparticularly at the g-secretase sites, we conclude that
Cortical neuronal cultures were established from brains of embry-
PS1 modulates trafficking of residual CTFs derived from onic day 15.5 fetal mice following published protocols (Yavin and
APP, APLP1, and perhaps other transmembrane pro- Yavin, 1980; Brewer et al., 1993). Briefly, the dissected brain cortexes
were suspended in HBSS supplemented with 0.25% trypsin andteins to degradative compartments, rather than acting
0.01% DNaseI and incubated at 378C for 20 min. The tissues wereas a ªchaperoneº that facilitates intramembrane cleav-
then transferred to Dulbecco's modified Eagle's medium (DMEM)age by specific proteases. The identities of compart-
supplemented with 10% fetal bovine serum and dissociated by re-ments involved in Ab production and/or degradation of
peated trituration. The dispersed cells were collected by centrifuga-
CTFs have not been determined, but internalization of tion and plated at z5 3 105 cells/35 mm dish (coated with polyethi-
APP from the cell surface and subsequent recycling renimine) in B27/Neurobasal media (GIBCO/BRL). Neurons were
allowed to mature for 4±7 days in culture before they were used forappears to be a significant pathway for generating se-
experiments.creted Ab peptides (Koo and Squazzo, 1994; Koo et al.,
1996).
Infection of Primary Cultures with RecombinantIn addition to showing that the metabolism of APP/
Adenovirus and Metabolic Labeling
APLP1 is altered in PS1-deficient neurons, we also re- APP recombinant adenovirus was prepared via homologous recom-
port that maturation of the tyrosine kinase receptor, bination in HEK293 cells using pJM17 and pCA4 vectors (Graham
TrkB, is affected by the loss of PS1. Specifically, we et al., 1977) in which the expressing of wild-type human APP695 is
under the control of the CMV promoter. The recombinants weredemonstrate that the rate of acquisition of complex oli-
expanded several times on HEK293 cells and purified on two suc-gosaccharides by TrkB core proteins is protracted in
cessive double cesium chloride gradients. The viral stock was ti-PS1-deficient neurons. More striking is our demonstra-
trated via a plaque assay. Primary neuronal cells cultured for 4
tion that the levels of BDNF-induced autophosphoryla- days were infected with 5 3 106 plaque-forming units of adenovirus
tion of TrkB receptors in PS12/2 neurons are nearly elimi- expressing human APP for 3 days in serum-free medium. For meta-
nated, and we would anticipate that TrkB-activated bolic labeling, neuronal cells were preincubated for 30 min in methio-
nine-free DMEM with 1% dialyzed bovine serum and then labeledintracellular signaling events might also be downregu-
with 700 mCi/ml of 35S-methionine in methionine-free medium for 5lated.
hr. For pulse-chase labeling, cells were pulsed for 1 hr (Figure 3)The role of PS1 in modulating trafficking and turnover
with methionine-free DMEM containing 1 mCi/ml 35S-methionine.
of selected membrane proteins in neurons is not yet Cells were then chased by washing and incubating in DMEM con-
clear. In view of the preponderant steady-state distribu- taining 1% dialyzed fetal bovine serum and 1 mM L-methionine at
tion of PS1 in the endoplasmic reticulum (ER) (Cook varying intervals, before the cells were lysed in immunoprecipitation
buffer containing detergents and a protease inhibitor cocktail (Si-et al., 1996; Kovacs et al., 1996; Lah et al., 1997), we
sodia et al., 1990).anticipated that PS1 deficiency might have more global
effects on secretory protein metabolism and turnover.
Determination of Ab1-42/43 and Ab1-40 LevelsHowever, and despite our demonstration that loss of
Two-site ELISAs that specifically detect the C terminus of Ab were
PS1 alters the metabolism of APP, APLP1, and TrkB, we performed to measure Ab levels as previously described (Suzuki et
neither found clear differences in the rate and patterns of al., 1994; Iwatsubo et al., 1996). Culture supernatants of neuronal
cells infected with adenovirus expressing human APP were col-appearance of anonymous polypeptides on the plasma
lected and analyzed using the BNT77/BA27 and BNT77/BC05 quan-membrane of PS11/2 and PS12/2 neurons, nor the rate
titative sandwich ELISA to determine Ab X-42/43 and Ab X-40 levels,of secretion of anonymous polypeptides in medium of
respectively.these cultures. However, it is instructive to note that in
yeast lacking membrane proteins, termed Emp24p and Immunoprecipitation and Immunoblotting
Erv25, the rate of delivery of a limited set of soluble After metabolic labeling, culture medium and cell extracts were
proteins from the ER to the Golgi is reduced and some immunoprecipitated as described previously (Sisodia et al., 1990).
Immunoprecipitates were fractionated on either 7% or 4%±20%resident ER proteins seem to escape (Schimmoller et
Tris-glycine or 16% Tris-tricine SDS-PAGE. Gels were dried, ex-al., 1995; Belden and Barlowe, 1996; Elrod-Erickson and
posed, and radioactive bands were quantified by phosphorimagingKaiser, 1996). Emp24p and Erv25 reside predominantly
analysis. For immunoblotting analysis, detergent lysates from neu-
in the ER and are incorporated equally into ER-derived ronal cells or fetal mouse brains were prepared as previously de-
vesicles when COPII-coated budding is reconstituted. scribed (Davis et al., 1998), and aliquots were fractionated on SDS-
Very interestingly, reducing the activity of C. elegans PAGE and subjected to immunoblotting with various antisera. Bound
primary antibodies were visualized with Protein A-HRP (Sigma, St.genes related to Emp24 and Erv25 suppresses certain
Louis, MO) and developed using the Renaissance kit (Dupont/NEN).partial loss-of-function mutations of lin-12/Notch (Chen-
hui Wen and Iva Greenwald, personal communication).
TrkB PhosphorylationIn view of the alterations in protein trafficking/secretion
TrkB phosphorylation was performed using methods previously de-
in PS1-deficient neurons, it is not inconceivable that scribed (Riccio et al., 1997). Briefly, neuronal cells were cultured for
PS1, like Emp24 and Erv25, might be a component of 6 days, and 100 ng/ml of BDNF was added to cultures for 10 min
the apparatus involved in selection and sorting of cargo at 378C. Cells were then washed in PBS at 48C, and cell lysates
were immunoprecipitated with a Trk C-terminal antibody, C14. Im-that exits from the ER. Similarly, the inefficient pro-
munoprecipitates were then fractionated on an 8% Tris-glycinecessing of APP and APLP1 CTF, events that occur late
SDS-PAGE and immunoblotted with phosphotyrosine-specificin the metabolism of the precursor proteins, might be
monoclonal antibodies, 4G10 and PY99.
the result of missorting of specific proteases or, alterna-
tively, accessory components that regulate vesicle bud- Cell Surface Labeling Studies
ding, targeting, and/or fusion events in the neuronal Cell-surface proteins were biotinylated essentially as described pre-
viously (Thinakaran et al., 1996). Briefly, cells were pulse-labeled forsecretory and/or endocytic pathways.
Neuron
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15 min with 35S-methionine, chased for 1 hr in medium containing NGF-stimulated retrograde transport of trkA in the mammalian ner-
vous system. J. Cell Biol. 130, 149±156.unlabeled methionine, then placed on ice. Cells were incubated with
0.5 mg/ml NHS-SS-biotin (Pierce) for 30 min, washed with buffer Elrod-Erickson, M.J., and Kaiser, C.A. (1996). Genes that control the
containing 1 mM CaCl2, 1 mM MgCl2, and 25 mM NH4Cl, then lysed fidelity of endoplasmic reticulum to Golgi transport as identified as
in immunoprecipitation buffer. Biotinylated proteins were captured suppressors of vesicle budding mutations. Mol. Biol. Cell 7, 1043±
using streptavidin-agarose beads (Pierce) and fractionated on SDS- 1058.
PAGE. Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. (1977). Charac-
teristics of a human cell line transformed by DNA from human adeno-
virus type 5. J. Gen. Virol. 36, 59±74.Acknowledgments
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